IBDEI0W7 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42295,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,42296,0)
 ;;=L27.0^^127^1844^265
 ;;^UTILITY(U,$J,358.3,42296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42296,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,42296,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,42296,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,42297,0)
 ;;=L27.1^^127^1844^266
 ;;^UTILITY(U,$J,358.3,42297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42297,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,42297,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,42297,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,42298,0)
 ;;=L29.0^^127^1844^250
 ;;^UTILITY(U,$J,358.3,42298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42298,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,42298,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,42298,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,42299,0)
 ;;=L29.9^^127^1844^251
 ;;^UTILITY(U,$J,358.3,42299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42299,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,42299,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,42299,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,42300,0)
 ;;=L30.0^^127^1844^232
 ;;^UTILITY(U,$J,358.3,42300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42300,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,42300,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,42300,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,42301,0)
 ;;=L30.1^^127^1844^140
 ;;^UTILITY(U,$J,358.3,42301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42301,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,42301,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,42301,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,42302,0)
 ;;=L30.2^^127^1844^132
 ;;^UTILITY(U,$J,358.3,42302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42302,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,42302,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,42302,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,42303,0)
 ;;=L30.4^^127^1844^144
 ;;^UTILITY(U,$J,358.3,42303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42303,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,42303,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,42303,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,42304,0)
 ;;=L30.8^^127^1844^135
 ;;^UTILITY(U,$J,358.3,42304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42304,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,42304,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,42304,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,42305,0)
 ;;=L30.9^^127^1844^136
 ;;^UTILITY(U,$J,358.3,42305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42305,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,42305,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,42305,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,42306,0)
 ;;=L40.0^^127^1844^253
 ;;^UTILITY(U,$J,358.3,42306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42306,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,42306,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,42306,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,42307,0)
 ;;=L40.1^^127^1844^256
 ;;^UTILITY(U,$J,358.3,42307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42307,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,42307,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,42307,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,42308,0)
 ;;=L40.2^^127^1844^11
 ;;^UTILITY(U,$J,358.3,42308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42308,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,42308,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,42308,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,42309,0)
 ;;=L40.3^^127^1844^255
 ;;^UTILITY(U,$J,358.3,42309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42309,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,42309,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,42309,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,42310,0)
 ;;=L40.4^^127^1844^157
 ;;^UTILITY(U,$J,358.3,42310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42310,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,42310,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,42310,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,42311,0)
 ;;=L40.8^^127^1844^252
 ;;^UTILITY(U,$J,358.3,42311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42311,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,42311,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,42311,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,42312,0)
 ;;=L40.9^^127^1844^254
 ;;^UTILITY(U,$J,358.3,42312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42312,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,42312,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,42312,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,42313,0)
 ;;=L50.9^^127^1844^286
 ;;^UTILITY(U,$J,358.3,42313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42313,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,42313,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,42313,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,42314,0)
 ;;=L53.8^^127^1844^147
 ;;^UTILITY(U,$J,358.3,42314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42314,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,42314,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,42314,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,42315,0)
 ;;=L53.9^^127^1844^146
 ;;^UTILITY(U,$J,358.3,42315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42315,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,42315,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,42315,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,42316,0)
 ;;=L54.^^127^1844^145
 ;;^UTILITY(U,$J,358.3,42316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42316,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,42316,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,42316,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,42317,0)
 ;;=L56.0^^127^1844^139
 ;;^UTILITY(U,$J,358.3,42317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42317,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,42317,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,42317,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,42318,0)
 ;;=L56.1^^127^1844^138
 ;;^UTILITY(U,$J,358.3,42318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42318,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,42318,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,42318,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,42319,0)
 ;;=L56.2^^127^1844^236
 ;;^UTILITY(U,$J,358.3,42319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42319,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,42319,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,42319,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,42320,0)
 ;;=L56.3^^127^1844^268
 ;;^UTILITY(U,$J,358.3,42320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42320,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,42320,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,42320,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,42321,0)
 ;;=L57.0^^127^1844^12
 ;;^UTILITY(U,$J,358.3,42321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42321,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,42321,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,42321,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,42322,0)
 ;;=L60.0^^127^1844^161
 ;;^UTILITY(U,$J,358.3,42322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42322,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,42322,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,42322,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,42323,0)
 ;;=L60.1^^127^1844^234
 ;;^UTILITY(U,$J,358.3,42323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42323,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,42323,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,42323,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,42324,0)
 ;;=L60.2^^127^1844^233
 ;;^UTILITY(U,$J,358.3,42324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42324,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,42324,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,42324,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,42325,0)
 ;;=L60.3^^127^1844^170
 ;;^UTILITY(U,$J,358.3,42325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42325,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,42325,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,42325,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,42326,0)
 ;;=L60.4^^127^1844^88
 ;;^UTILITY(U,$J,358.3,42326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42326,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,42326,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,42326,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,42327,0)
 ;;=L60.5^^127^1844^290
 ;;^UTILITY(U,$J,358.3,42327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42327,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,42327,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,42327,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,42328,0)
 ;;=L60.8^^127^1844^168
 ;;^UTILITY(U,$J,358.3,42328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42328,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,42328,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,42328,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,42329,0)
 ;;=L62.^^127^1844^169
 ;;^UTILITY(U,$J,358.3,42329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42329,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,42329,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,42329,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,42330,0)
 ;;=L64.9^^127^1844^33
 ;;^UTILITY(U,$J,358.3,42330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42330,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,42330,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,42330,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,42331,0)
 ;;=L65.9^^127^1844^231
 ;;^UTILITY(U,$J,358.3,42331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42331,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,42331,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,42331,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,42332,0)
 ;;=L70.0^^127^1844^6
 ;;^UTILITY(U,$J,358.3,42332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42332,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,42332,1,4,0)
 ;;=4^L70.0
